Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Bonelli, Lorenza"" wg kryterium: Autor


Wyświetlanie 1-14 z 14
Tytuł :
Neuroregulation of the Hypothalamus-Pituitary-Adrenal (HPA) Axis in Humans: Effects of GABA-, Mineralocorticoid-, and GH-Secretagogue-Receptor Modulation
Autorzy :
Giordano, Roberta
Pellegrino, Micaela
Picu, Andreea
Bonelli, Lorenza
Balbo, Marcella
Berardelli, Rita
Lanfranco, Fabio
Ghigo, Ezio
Arvat, Emanuela
Pokaż więcej
Temat :
feedback
endocrine system
cortisol
Review Article
ghrelin
benzodiazepines
GHS
ACTH
humans
hormones, hormone substitutes, and hormone antagonists
Źródło :
The Scientific World Journal
Tytuł :
The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing’s disease
Autorzy :
Giordano, Roberta
Picu, Andrea
Pagotto, Uberto
De Iasio, Rosaria
Bonelli, Lorenza
Prodam, Flavia
Broglio, Fabio
Marafetti, Lisa
Pasquali, Renato
Maccario, Mauro
Ghigo, Ezio
Arvat, Emanuela
Pokaż więcej
Źródło :
European Journal of Endocrinology; October 2005, Vol. 153 Issue: 4 p535-543, 9p
Periodyk
Tytuł :
Excess Morbidity Persists in Patients With Cushing's Disease During Long-term Remission: A Swedish Nationwide Study.
Autorzy :
Papakokkinou E; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; The Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Olsson DS; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; The Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Chantzichristos D; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; The Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Dahlqvist P; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Segerstedt E; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Olsson T; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Petersson M; Department of Molecular Medicine and Surgery, Karolinska Institutet and The Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Berinder K; Department of Molecular Medicine and Surgery, Karolinska Institutet and The Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Bensing S; Department of Molecular Medicine and Surgery, Karolinska Institutet and The Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Höybye C; Department of Molecular Medicine and Surgery, Karolinska Institutet and The Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Edén-Engström B; Department of Medical Sciences; Endocrinology, Diabetes and Metabolism, Uppsala University Hospital, Uppsala, Sweden.
Burman P; Department of Endocrinology, Skåne University Hospital, University of Lund, Malmö, Sweden.
Bonelli L; Department of Endocrinology, Skåne University Hospital, University of Lund, Malmö, Sweden.
Follin C; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Petranek D; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Erfurth EM; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Wahlberg J; Department of Endocrinology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Ekman B; Department of Endocrinology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Åkerman AK; Department of Internal Medicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Schwarcz E; Department of Internal Medicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Bryngelsson IL; Department of Occupational and Environmental Medicine, University Hospital, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Johannsson G; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; The Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Ragnarsson O; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; The Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Pokaż więcej
Źródło :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Aug 01; Vol. 105 (8).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Pituitary ACTH Hypersecretion/*epidemiology
Sepsis/*epidemiology
Stroke/*epidemiology
Thromboembolism/*epidemiology
Adult ; Aged ; Comorbidity ; Female ; Follow-Up Studies ; Fractures, Bone/epidemiology ; Glucocorticoids/therapeutic use ; Humans ; Incidence ; Male ; Medical Records/statistics & numerical data ; Middle Aged ; Neoplasms/epidemiology ; Pituitary ACTH Hypersecretion/drug therapy ; Remission Induction ; Retrospective Studies ; Risk Factors ; Sweden/epidemiology
Czasopismo naukowe
Tytuł :
Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study.
Autorzy :
Ragnarsson O; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden.
Olsson DS; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden.
Papakokkinou E; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden.
Chantzichristos D; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden.
Dahlqvist P; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Segerstedt E; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Olsson T; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Petersson M; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Berinder K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Bensing S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Höybye C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden.
Edén-Engström B; Department of Medical Sciences; Endocrinology, Diabetes and Metabolism, Uppsala University Hospital, Uppsala, Sweden.
Burman P; Department of Endocrinology, Skåne University Hospital, University of Lund, Malmö, Sweden.
Bonelli L; Department of Endocrinology, Skåne University Hospital, University of Lund, Malmö, Sweden.
Follin C; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Petranek D; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Erfurth EM; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Wahlberg J; Department of Endocrinology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Ekman B; Department of Endocrinology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Åkerman AK; Department of Internal Medicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Schwarcz E; Department of Internal Medicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Bryngelsson IL; Department of Occupational and Environmental Medicine, Örebro University Hospital, Örebro, Sweden.
Johannsson G; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden.
Pokaż więcej
Źródło :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2019 Jun 01; Vol. 104 (6), pp. 2375-2384.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Pituitary ACTH Hypersecretion/*mortality
Adult ; Cardiovascular Diseases/mortality ; Female ; Hormone Replacement Therapy ; Humans ; Male ; Middle Aged ; Pituitary ACTH Hypersecretion/therapy ; Proportional Hazards Models ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.
Autorzy :
Giordano R; Division of Endocrinology and Metabolism, Department of Internal Medicine, Ospedale Molinette, University of Turin, Italy.
Bo M
Pellegrino M
Vezzari M
Baldi M
Picu A
Balbo M
Bonelli L
Migliaretti G
Ghigo E
Arvat E
Pokaż więcej
Źródło :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2005 Oct; Vol. 90 (10), pp. 5656-62. Date of Electronic Publication: 2005 Jul 12.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Mineralocorticoid Receptor Antagonists*/adverse effects
Mineralocorticoid Receptor Antagonists*/pharmacology
Aging/*physiology
Hypothalamo-Hypophyseal System/*drug effects
Hypothalamo-Hypophyseal System/*growth & development
Pituitary-Adrenal System/*drug effects
Pituitary-Adrenal System/*growth & development
Adrenocorticotropic Hormone/blood ; Adult ; Aged ; Canrenoic Acid/adverse effects ; Canrenoic Acid/pharmacology ; Circadian Rhythm/physiology ; Dehydroepiandrosterone/blood ; Drug Resistance ; Female ; Humans ; Hydrocortisone/blood ; Male ; Spironolactone/adverse effects ; Spironolactone/pharmacology ; Stimulation, Chemical
Czasopismo naukowe
    Wyświetlanie 1-14 z 14

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies